Endometriosis affects 15% of menstruating individuals, causing debilitating pain and infertility. Despite this, diagnosis is challenging due to invasive, uncomfortable methods requiring specialist visits. Discova aims to revolutionize this with an at-home device to capture a sample of a person's period, that is then shipped to a lab and analyzed. This opportunity has a TAM of $5.3 Million, with expansion potential into adjacent verticals.